BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9258273)

  • 1. Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study.
    Mauras N; Vieira NE; Yergey AL
    Metabolism; 1997 Aug; 46(8):908-13. PubMed ID: 9258273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens do not affect whole-body protein metabolism in the prepubertal female.
    Mauras N
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2842-5. PubMed ID: 7559861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
    Copeland KC
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
    Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination growth hormone and estrogen increase bone mineralization in girls with Turner syndrome.
    Beckett PR; Copeland KC; Flannery TK; Sherman LD; Abrams SA
    Pediatr Res; 1999 May; 45(5 Pt 1):709-13. PubMed ID: 10231869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study.
    Mauras N; Hayes VY; Vieira NE; Yergey AL; O'Brien KO
    J Bone Miner Res; 1999 Apr; 14(4):577-82. PubMed ID: 10234579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy.
    Lanes R; Gunczler P; Paoli M; Weisinger JR
    Horm Res; 1995; 44(4):168-71. PubMed ID: 8522278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement.
    Veldhuis JD; Metzger DL; Martha PM; Mauras N; Kerrigan JR; Keenan B; Rogol AD; Pincus SM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3414-20. PubMed ID: 9329378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.
    Naeraa RW; Brixen K; Hansen RM; Hasling C; Mosekilde L; Andresen JH; Charles P; Nielsen J
    Calcif Tissue Int; 1991 Aug; 49(2):77-83. PubMed ID: 1913298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen therapy in Turner's syndrome.
    Cutler GB; Ross JL
    Acta Paediatr Jpn; 1992 Apr; 34(2):195-202; discussion 202-5. PubMed ID: 1621525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.
    Stĕpán JJ; Musilová J; Pacovský V
    J Bone Miner Res; 1989 Apr; 4(2):193-8. PubMed ID: 2786321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal dysgenesis and bone metabolism.
    Breuil V; Euller-Ziegler L
    Joint Bone Spine; 2001 Feb; 68(1):26-33. PubMed ID: 11235777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
    Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.